"Le CHU de Rouen, au cœur du Campus Santé Rouen Normandie, contribue au développement d’un véritable écosystème dédié à la santé. Ses 10 300 professionnels sont au service d'une triple mission : soigner et prendre soin de chaque patient, former les futurs médecins et soignants et faire avancer la recherche au bénéfice de tous. Avec ses 5 établissements de soins et d'hébergement, le CHU de Rouen est l’établissement support du Groupement hospitalier de territoire (GHT) Rouen Cœur de Seine. Premier employeur de Normandie, il se positionne parmi les 12 plus importants CHU français en termes d’activités."

During the past decade, Virologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Virologie" are "Cytomegalovirus" (1 trials) and "Transplant Recipients With CMV Infection" (1 trials). Many other conditions were trialed in "Virologie" in a lesser frequency.

Most popular intervention types in "Virologie" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "CMV Infection" (1 trials) and "depistage" (1 trials). Other intervention names were less common.

The vast majority of trials in "Virologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Virologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Virologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Virologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".